Physical Activity Program for Counteracting Sarcopenia
EXERSARCO
Effects of an Home-base Physical Activity Program for Counteracting Sarcopenia in Elderly: a Randomized-controlled Trial.
1 other identifier
interventional
16
1 country
1
Brief Summary
Sarcopenia is a pathophysiological process associated with aging and some metabolic conditions characterized by progressive muscle tissue loss, which may lead to loss of strangth and performance and increase risk of falls and fractures, physical disability and premature death. Therefore, it is necessary to identify personalized programs of physical activity and supplementation for elderly population in order to improve their physical functions, muscle strengh and body composition. With the present project we aime to assess the effect of a feasible home-based exercise program coupled with food supplementation to improve muscle strength, muscle volume and muscle physical performance potentially associated with sarcopenia in elderly people.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 18, 2019
CompletedFirst Submitted
Initial submission to the registry
November 13, 2019
CompletedFirst Posted
Study publicly available on registry
November 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2021
CompletedFebruary 9, 2021
February 1, 2021
2.3 years
November 13, 2019
February 8, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Lower limb strength
Assessed by chair stand test
Baseline and Week 24
Secondary Outcomes (5)
Body composition
Baseline and Week 24
Quantify thigh cross sectional area
Baseline and Week 24
Maximum isometric force that a hand can squeeze
Baseline and Week 24
Maximal Isometric Strength of Knee flexors and extensors
Baseline AND Week 24
Dynamic balance and gait deficits
Baseline and Week 24
Study Arms (3)
Physical activity group
EXPERIMENTALPhysical activity and supplementation group
EXPERIMENTALControl group
EXPERIMENTALInterventions
Home-based physical activity program and amminoacid supplementation
Eligibility Criteria
You may qualify if:
- Sedentary lifestyle.
- Cognitively intact.
- Autonomous walking.
- Acceptance of informed consent.
You may not qualify if:
- Body mass index lower than 18.5 and uppen than 40 kg/m2.
- History of cancer.
- Pacemaker user.
- History of epileptic episodes.
- Endocrine-metabolic, neurological, muscular and ortopedic pathologies that affect movement functions.
- Bone fractures that influence movement functions.
- Smoking.
- Surgical treatments in the prior 6 months.
- Use of antieptilectics, glucocorticoids, rhGH and testosterone.
- Hepatic and muscular pathologies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Istituto Ortopedico Galeazzi
Milan, 20141, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2019
First Posted
November 21, 2019
Study Start
September 18, 2019
Primary Completion
December 20, 2021
Study Completion
December 20, 2021
Last Updated
February 9, 2021
Record last verified: 2021-02